O'Connor Donal bought TBPH
June 12, 2026 · Form 4 insider transaction
O'Connor Donal bought 6,009 shares of Theravance Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,009
Price
$0.00
Total value
N/A
InsiderO'Connor Donal
RoleDirector
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateJune 12, 2026
Filing dateJune 16, 2026
Shares owned after80,213
OwnershipDirect
10b5-1 planNo
AmendedNo